Clinical Trial

Observation of Clinical Consistency of Organoid-chips Drug Sensitivity in Chemotherapy for PCa With Visceral Metastasis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 5, 2024 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This project plans to establish an organoid chip model of prostate cancer patients with internal organ metastasis from surgical or biopsy tissue sources, and test the sensitivity of commonly used chemotherapy drugs based on organoid chip drug sensitivity testing technology to screen out sensitive individualized treatment plans.
Trial Details
NCT Number NCT06536725
Lead Sponsor Tianjin Medical University Second Hospital
Conditions Prostate Cancer, Organoid
Enrollment 35 participants
Start Date 2024-06-01
Primary Completion 2025-11-01 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-05